AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: | Completed |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/2/2016 |
Start Date: | September 2010 |
End Date: | December 2012 |
Contact: | Jenna Piel |
Email: | j.piel@imedsonline.com |
Phone: | 951-653-5566 |
The purpose of this study is to compare the visual outcomes with bilateral implantation of
Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
The purpose of this study is to compare the visual outcomes with bilateral implantation of
Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
Inclusion Criteria:
- Age 18 or greater
- Bilateral condition (cataracts or Presbyopia) for which phacoemulsification and
posterior IOL implantation has been planned for both eyes
- Visual potential of 20/25 or better in each eye after cataract removal and IOL
implantation
- Clear intraocular media other than cataract
- Normal OCT of the macula
- No evidence of Keratoconus or significant irregular astigmatism on Preoperative
topography
- No evidence of Epithelial Basement Membrane Dystrophy on Slit lamp Exam
- Availability, willingness, and sufficient cognitive awareness to comply with
examination procedures
Exclusion Criteria:
- Use of systemic or ocular medications that may affect vision
- Uncontrolled systemic or ocular disease
- History of ocular trauma
- History of intraocular, extraocular Muscle, or corneal surgery (including laser
vision correction)
- Amblyopia or strabismus
- Known pathology that may affect visual acuity; particularly retinal changes that
affect vision (macular degeneration, cystoid macular edema, proliferative diabetic
retinopathy, etc.)
- Diagnosed degenerative visual disorders (e.g. macular degeneration, or other retinal
disorders) that are predicted to cause future acuity losses to a level of 20/25 or
worse
- Subjects who may be expected to require retinal laser treatment or other surgical
intervention (i.e patients with diabetic retinopathy)
- Capsule or zonular abnormalities that may affect postoperative centration or tilt of
the lens (e.g. pseudoexfoliation syndrome)
- Contact lens usage within 2 months for PMMA contacts lenses, 2 weeks for gas
permeable lenses or 3 days for extended-wear and daily-wear soft contact lenses
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials